This is an old revision of this page, as edited by Stuartyeates (talk | contribs) at 20:40, 2 September 2014 (Nominated for deletion; see Misplaced Pages:Articles for deletion/Ronald R. Fieve.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 20:40, 2 September 2014 by Stuartyeates (talk | contribs) (Nominated for deletion; see Misplaced Pages:Articles for deletion/Ronald R. Fieve.)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)| An editor has nominated this article for deletion. You are welcome to participate in the deletion discussion, which will decide whether or not to retain it.Feel free to improve the article, but do not remove this notice before the discussion is closed. For more information, see the guide to deletion. Find sources: "Ronald R. Fieve" – news · newspapers · books · scholar · JSTOR%5B%5BWikipedia%3AArticles+for+deletion%2FRonald+R.+Fieve%5D%5DAFD |
Ronald R. Fieve is a psychiatrist in New York, United States. He received his medical degree from Harvard Medical School. He undertook his residencies at New York Presbyterian Hospital, and later became clinical professor at Columbia Presbyterian Medical Center. He is considered a pioneer in the use and promotion in America of the medication lithium for mood disorders. He has authored three popular books, "Prozac", "Moodswing" and "Bipolar II". He has a private practice and research offices in Manhattan and at the Columbia-Presbyterian Medical Center.
References
- PsychCentral Ronald Fieve
- Lithium: From Introduction to Public Awareness. Ronald R. Fieve Pg 258 to 260, The Triumph of Psychopharmacology and the story of CINP (International College of NeuroPsychoPhamarcology)
 | This article has not been added to any content categories. Please help out by adding categories to it so that it can be listed with similar articles. (September 2014) |